T790M mutations identified by circulating tumor DNA test in lung adenocarcinoma patients who progressed on first-line epidermal growth factor receptor-tyrosine kinase inhibitors

BACKGROUND: Plasma circulating tumor deoxyribonucleic acid (ctDNA) test is an alternative method to detect the T790M mutation. Compared to conventional tumor rebiopsy, ctDNA possesses several advantages including less invasive, faster, lower costs, and having minimal risk of complications for patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Merinda, Vinodini, Soegiarto, Gatot, Wulandari, Laksmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961098/
https://www.ncbi.nlm.nih.gov/pubmed/31898615
http://dx.doi.org/10.4103/lungindia.lungindia_182_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961098/
https://www.ncbi.nlm.nih.gov/pubmed/31898615
http://dx.doi.org/10.4103/lungindia.lungindia_182_19

Ejemplares similares